The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial Diseases

Author:

Chen Tingkai1,Sun Tianyu1,Bian Yaoyao2,Pei Yuqiong3,Feng Feng4,Chi Heng4,Li Yuan5,Tang Xu3,Sang Shenghu3,Du Chenxi1,Chen Ying1,Chen Yao3ORCID,Sun Haopeng1ORCID

Affiliation:

1. School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People’s Republic of China

2. College of Acupuncture and Massage, College of Regimen and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing 210023, People’s Republic of China

3. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, People’s Republic of China

4. Food and Pharmaceutical Research Institute, Jiangsu Food and Pharmaceuticals Science College, Huaian 223003, People’s Republic of China

5. Department of Pharmaceutical Engineering, Jiangsu Food and Pharmaceuticals Science College, Huaian 223005, People’s Republic of China

Funder

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Natural Science Research Project of Higher Education Institutions in Jiangsu Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease;European Journal of Medicinal Chemistry;2024-12

2. Glucagon-like peptide-1 analogs: Miracle drugs are blooming?;European Journal of Medicinal Chemistry;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3